ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,360.79
0.26%
Dow Jones
38,868.04
0.18%
US Dollar vs MXN
18.4298
-0.78%
Brent Oil
81.335
-0.54%
Bitcoin
66,812.03
-3.88%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Nuo Therapeutics Inc (QB) (AURX)

  7. Nuo Therapeutics Inc (QB) (AURX) Noticias

AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:AURX
FechaHoraFuenteTítuloSímboloCompañía
22/05/202411:40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202414:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202407:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
14/02/202412:58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
12/02/202416:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
20/12/202313:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202308:37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202316:10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202305:08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
14/11/202217:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202207:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202207:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202207:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
10/08/202212:29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202207:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202207:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AURXNuo Therapeutics Inc (QB)
19/05/202215:35Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AURXNuo Therapeutics Inc (QB)
27/04/202215:20Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AURXNuo Therapeutics Inc (QB)
31/03/202215:47Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:AURXNuo Therapeutics Inc (QB)
21/03/202209:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)USOTC:AURXNuo Therapeutics Inc (QB)
04/02/202216:03Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)USOTC:AURXNuo Therapeutics Inc (QB)
21/01/202210:29Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)USOTC:AURXNuo Therapeutics Inc (QB)
09/10/202014:30Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AURXNuo Therapeutics Inc (QB)
13/11/201915:32Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/201915:21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:AURXNuo Therapeutics Inc (QB)
04/08/201715:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:AURXNuo Therapeutics Inc (QB)
30/06/201716:25Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AURXNuo Therapeutics Inc (QB)
20/04/201713:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AURXNuo Therapeutics Inc (QB)
11/04/201705:17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AURXNuo Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AURX

Su Consulta Reciente

LSE
CKGG
Green Energy
BIT
P20AS3
NLBNPIT20AS3 20351221 2....
BIT
RCS
Rizzoli Corriere della S...
COIN
SLNDETH
Solend
BOV
ITUBP25
ITUBP25 Ex:22,71
BIT
WNER
Wisdomtree New Economy R...
COIN
DGMGBP
BIBX
CSSUSDT
Cercle Stock Service
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados